Category: Conferences
Search News
Blood test helps guide immunotherapy for bladder cancer
22nd October 2025
A new clinical trial led by Professor Thomas Powles at Barts Cancer Institute, Queen Mary University of London, has shown that a blood test to detect tumour DNA could help doctors decide which patients with bladder cancer are most likely to benefit from further treatment after surgery. The new approach improved survival in those identified as high-risk while safely sparing low-risk patients from unnecessary side effects.
Read more
Groundbreaking trials reveal improved survival for two hard-to-treat cancers
16th September 2024
Prof Tom Powles and Prof Peter Schmid announced practice-changing results at ESMO 2024
Read more
Immunotherapy drug improves survival for people with kidney cancer in landmark clinical trial
19th April 2024
Professor Tom Powles and team reveal first successful adjuvant therapy for kidney cancer in 50 years.
Read more
Future leaders in focus: highlights from the CRUK City of London Centre Symposium 2024
27th February 2024
Experts in the field converged to discuss the latest advances in pancreatic cancer
Read more
New drug combination doubles survival for people with bladder cancer
25th October 2023
Clinical trial results from BCI and Barts NHS trust provide new hope for people with bladder cancer.
Read more
Coming together to tackle pancreatic cancer – The London Pancreas Workshop
29th June 2023
Experts in the field converged to discuss the latest advances in pancreatic cancer
Read more